START - San Antonio - EDOS

San Antonio, Texas 78229-3307

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer — Recruiting now